![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/39 | |
A61P 31/04 | |||
A61P 33/00 | |||
A61P 37/04 |
(11) | Number of the document | 1292333 |
(13) | Kind of document | T |
(96) | European patent application number | 01945376.0 |
Date of filing the European patent application | 2001-06-07 | |
(97) | Date of publication of the European application | 2003-03-19 |
(45) | Date of publication and mention of the grant of the patent | 2007-02-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/FR2001/001769 |
Date | 2001-06-07 |
(87) | Number | WO 2001/093906 |
Date | 2001-12-13 |
(30) | Number | Date | Country code |
0007302 | 2000-06-07 | FR |
(72) |
CAPRON, André, FR
LOCHT, Camille, BE
MENOZZI, Franco, BE
POULAIN-GODEFROY, Odile, FR
RIVEAU, Gilles, FR
|
(73) |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),
101, rue de Tolbiac, 75654 Paris Cédex 13,
FR
INSTITUT PASTEUR DE LILLE, 1, rue du Professeur Calmette BP 245, 59019 Lille Cédex, FR |
(54) | COMPOSITION ADJUVANTE COMPRENANT LA PROTEINE FHA OU UN FRAGMENT DE LA PROTEINE FHA SOUS FORME LIBRE |
ADJUVANT COMPOSITION COMPRISING FHA PROTEIN OR FRAGMENT OF FHA PROTEIN IN FREE FORM |